Innovator IBD 50 ETF (NYSEARCA:FFTY) Trading Down 1.3% – Should You Sell?

Innovator IBD 50 ETF (NYSEARCA:FFTY) fell 1.3% during mid-day trading on Tuesday . The company traded as low as $36.72 and last traded at $37.74. 45,398 shares were traded during trading, a decline of 56% from the average session volume of 103,058 shares. The stock had previously closed at $38.23.

Innovator IBD 50 ETF Trading Down 1.3%

The firm has a market cap of $90.58 million, a price-to-earnings ratio of 30.34 and a beta of 1.35. The stock’s 50 day moving average is $36.55 and its 200 day moving average is $36.51.

Innovator IBD 50 ETF Announces Dividend

The company also recently announced an annual dividend, which was paid on Friday, January 2nd. Stockholders of record on Wednesday, December 31st were paid a dividend of $0.469 per share. The ex-dividend date was Wednesday, December 31st. This represents a dividend yield of 135.0%.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. AlphaCore Capital LLC acquired a new stake in shares of Innovator IBD 50 ETF during the fourth quarter worth $32,000. International Assets Investment Management LLC bought a new position in Innovator IBD 50 ETF during the fourth quarter worth about $35,000. Advisory Services Network LLC acquired a new stake in Innovator IBD 50 ETF in the 3rd quarter worth about $43,000. Simplex Trading LLC acquired a new stake in Innovator IBD 50 ETF in the 4th quarter worth about $41,000. Finally, Kestra Advisory Services LLC bought a new stake in Innovator IBD 50 ETF in the 4th quarter valued at about $72,000.

Innovator IBD 50 ETF Company Profile

The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is managed by Innovator.